Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H GOLDFARB

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
In Vivo (Athens, Greece)|December 28, 2000
Regulation of IFN-gamma production following 2B4 activation in human NK cellsL A Johnson, R H Goldfarb, P A Mathew
Thrombosis Research|March 15, 1981
Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of lamininL A Liotta, R H Goldfarb, V P Terranova
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distributionA A Maghazachi, R H Goldfarb, R B Herberman
Natural Immunity|September 1, 1995
Non-granular proteolytic enzymes of rat interleukin-2-activated natural killer cells. III. Enhancement of A-NKP 1, 2, and 3 proteolytic activities (cleaving after Arg, Phe and Pro) in response to interleukin-2R P Kitson, C A Miller, R H Goldfarb
In Vivo (Athens, Greece)|January 19, 1999
Cytolytic activities of IL-2 activated NK cells from MMTV/v-Ha-ras transgenic oncomice during tumor progressionR H Goldfarb, P Albertsson, U Nannmark, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1986
Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesisR H Goldfarb, M Ziche, G Murano, et al.
In Vivo (Athens, Greece)|April 11, 2000
Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domainsR P Kitson, M Lu, R Siman, et al.
Cell Death and Differentiation|January 23, 1999
Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblastsB An, R H Goldfarb, R Siman, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labelsP Basse, R B Herberman, M Hokland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional roleR H Goldfarb, K Wasserman, R B Herberman, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
In Vivo (Athens, Greece)|December 28, 2000
Regulation of IFN-gamma production following 2B4 activation in human NK cellsL A Johnson, R H Goldfarb, P A Mathew
Thrombosis Research|March 15, 1981
Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of lamininL A Liotta, R H Goldfarb, V P Terranova
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distributionA A Maghazachi, R H Goldfarb, R B Herberman
Natural Immunity|September 1, 1995
Non-granular proteolytic enzymes of rat interleukin-2-activated natural killer cells. III. Enhancement of A-NKP 1, 2, and 3 proteolytic activities (cleaving after Arg, Phe and Pro) in response to interleukin-2R P Kitson, C A Miller, R H Goldfarb
In Vivo (Athens, Greece)|January 19, 1999
Cytolytic activities of IL-2 activated NK cells from MMTV/v-Ha-ras transgenic oncomice during tumor progressionR H Goldfarb, P Albertsson, U Nannmark, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1986
Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesisR H Goldfarb, M Ziche, G Murano, et al.
In Vivo (Athens, Greece)|April 11, 2000
Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domainsR P Kitson, M Lu, R Siman, et al.
Cell Death and Differentiation|January 23, 1999
Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblastsB An, R H Goldfarb, R Siman, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labelsP Basse, R B Herberman, M Hokland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional roleR H Goldfarb, K Wasserman, R B Herberman, et al.
Pageof 8